Inhibition of autophagy promotes the anti-tumor effect of metformin in oral squamous cell carcinoma

HIGHLIGHTS

• who: Wei Zhao et al. from the Department of Stomatology, Changzheng Hospital, Naval Medical University, Shanghai, China have published the research work: Inhibition of Autophagy Promotes the Anti-Tumor Effect of Metformin in Oral Squamous Cell Carcinoma, in the Journal: Cancers 2022, x of /2022/
• what: The study investigated the anti-tumor activity of metformin (the first-line diabetes drug) in OSCC. The study showed that metformin could inhibit the proliferation, migration, and invasion of OSCC, and could promote OSCC cell apoptosis and autophagy.
• how: The data showed that metformin could enhance the . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.